ArticleCurrent neuropharmacology2022

Mitochondrial Dysfunction in Alzheimer's Disease: Opportunities for Drug Development.

Shiveena Bhatia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.